Tobacco addiction, arguably the most significant and deadly of the modifiable cardiovascular
risk factors—and the most neglected—has long been a challenge for the cardiovascular
specialist.
1
Notwithstanding the significant reduction in smoking that has occurred in Canada
over the past 50 years—only 14%-16% of Canadians are now smokers—it remains a persistent
pathologic feature of the lives of many of our patients. Cardiovascular clinicians
have been enjoined to address the challenge of smoking cessation by supporting a systematic
approach to the management of their smoking patients with the use of cessation aids
and supportive counselling.
2
Smoking cessation is not easy. Nicotine is the most addictive product encountered
in the community. Most smokers know why they should not smoke and do not wish to be
smokers, and many of them make several, unsuccessful private attempts to quit each
year. Given the carnage that results from tobacco addiction, opportunities to assist
cessation are to be welcomed. The suggestion, therefore, that the introduction of
vaping devices, or electronic nicotine delivery systems (ENDS), would facilitate cessation
and mitigate the harms of smoking warrants careful consideration.
3
,
4
,
5
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Managing tobacco use: the neglected cardiovascular disease risk factor.Eur Heart J. 2013; 3: 3259-3267
- Smoking cessation and the cardiovascular specialist: Canadian Cardiovascular Society position paper.Can J Cardiol. 2011; 2: 132-137
- Cardiovascular effects of switching from tobacco cigarettes to electronic cigarettes.J Am Coll Cardiol. 2019; 7: 3112-3120
- Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives.Annu Rev Public Health. 2018; 3: 193-213
- The promise and peril of vaping.Curr Cardiol Rep. 2020; 2: 155
- Vaping instead of cigarette smoking: a panacea or just another form of cardiovascular risk?.Can J Cardiol. 2021; 37: 690-698
- Vaping: The new wave of nicotine addiction.Cleve Clin J Med. 2019; 8: 789-798
- Electronic cigarettes and adolescents.Can Fam Physician. 2016; 6: 897-898
- Quantifying population-level health benefits and harms of e-cigarette use in the United States.PLoS One. 2018; 1e0193328
- Adolescents’ use of “pod mod” e-cigarettes—urgent concerns.N Engl J Med. 2018; 3: 1099-1102
- Public health considerations for adolescent initiation of electronic cigarettes.Pediatrics. 2020; 145: S175-S180
- The gateway effect of e-cigarettes: reflections on main criticisms.Nicotine Tob Res. 2019; 2: 695-698
- Association of electronic cigarette use with subsequent initiation of tobacco cigarettes in US youths.JAMA Netw Open. 2019; 2e187794
- Association of e-cigarette use with respiratory disease among adults: a longitudinal analysis.Am J Prev Med. 2020; 5: 182-190
- Pulmonary toxicity of e-cigarettes.Am J Physiol Lung Cell Mol Physiol. 2017; 3: L193-L206
- Vaping-induced lung disease—a look forward by looking back.N Engl J Med. 2020; 3: 1649-1650
- What are the respiratory effects of e-cigarettes?.BMJ. 2019; 3: l5275
- The evolving landscape of e-cigarettes: a systematic review of recent evidence.Chest. 2020; 1: 1362-1390
- E-cigarettes and respiratory health: the latest evidence.J Physiol. 2020; 5: 5027-5038
- e-Cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion.Am J Respir Crit Care Med. 2018; 1: 492-501
- e-Cigarette use and asthma in a multiethnic sample of adolescents.Prev Med. 2017; 1: 226-231
- Vaping and respiratory viruses: the end for ENDS?.Am J Respir Cell Mol Biol. 2021; 64: 16-18
- Effects of e-cigarettes and vaping devices on cardiac and pulmonary physiology.J Physiol. 2020; 5: 5039-5062
- Association between e-cigarette use and chronic obstructive pulmonary disease by smoking status: Behavioral Risk Factor Surveillance System 2016 and 2017.Am J Prev Med. 2020; 5: 336-342
- A nasty case of the vapours—e-cigarettes friend or foe?.J Physiol. 2020; 5: 5025
- e-Cigarettes: use, effects on smoking, risks, and policy implications.Annu Rev Public Health. 2018; 3: 215-235
- A randomized trial of e-cigarettes versus nicotine-replacement therapy.N Engl J Med. 2019; 3: 629-637
- Electronic cigarettes for smoking cessation.Cochrane Database Syst Rev. 2020; 1: CD010216
- Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: the PATH study 2013-16.PLoS One. 2020; 1e0237938
- Public Health Consequences of e-Cigarettes.National Academies Press, Washington, DC2018
- E-cigarettes: striking the right balance.Lancet Public Health. 2020; 5: e180-e181
- Electronic cigarettes: a position statement from the Thoracic Society of Australia and New Zealand.Respirology. 2020; 2: 1082-1089
- Are long-term vapers interested in vaping cessation support?.Addiction. 2019; 1: 1473-1477
- Is vaping cessation like smoking cessation? A qualitative study exploring the responses of youth and young adults who vape e-cigarettes.Addict Behav. 2021; 1: 106687
- The past is not the future in tobacco control.Prev Med. 2020; 1: 106183
- Global approaches to regulating electronic cigarettes.Tob Control. 2017; 2: 440-445
- Binge vaping, a dangerous new COVID-19 coping strategy among some teenagers in Montréal.CTV News Montréal. January 23, 2021;
- Concentration of nicotine in vaping products regulations.Government of Canada, Ottawa2020
Article info
Publication history
Published online: April 07, 2021
Accepted:
February 3,
2021
Received:
January 8,
2021
Footnotes
See article by Nayeri and Middlekauff, pages 690–698 of this issue.
See page 684 for disclosure information.
Identification
Copyright
© 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Vaping Instead of Cigarette Smoking: A Panacea or Just Another Form of Cardiovascular Risk?Canadian Journal of CardiologyVol. 37Issue 5
- PreviewSince 2007, the electronic cigarette (EC), with its increasingly diverse array of device options, has gained popularity both among long-term tobacco cigarette (TC) smokers and among never-smoking youth. The absence of a number of known toxic by-products of TC smoking has helped cultivate the perception that ECs are healthy. However, an expanding literature has provided concerning evidence that a number of EC constituents, including nicotine, and their thermal degradation by-products may have adverse effects, including cardiovascular effects.
- Full-Text
- Preview
